Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2003
10/01/2003EP1347770A2 Method of making a protein polymer and uses of the polymer
10/01/2003EP1347730A2 Recombinant anti-cd30 antibodies and uses thereof
10/01/2003EP1100830B1 Heterominibodies
10/01/2003EP0914043B1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
10/01/2003EP0894146B1 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer metastasis formation
10/01/2003EP0809691B1 Submucosa as a growth substrate for cells
10/01/2003EP0783511B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
10/01/2003CN1446260A Lipoxygenase genes, promoters, transit peptides and protein thereof
10/01/2003CN1446256A Mammalian gamete and embryo culture media supplement and method of using same
10/01/2003CN1446228A 校正基因 Correction gene
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1445363A Method for directional differentiating human embryonic stem cell to epidermis stem cell by induction in vitro
10/01/2003CN1444992A Method and combination for treating tumors based on ERBB-3
10/01/2003CN1122719C Modified biological material
10/01/2003CN1122716C Extracorporeal ceel culture and transplantation kits
10/01/2003CN1122715C Medusa-snow lotus cell system for generating flavone with high output
10/01/2003CN1122530C Vacines
09/2003
09/30/2003US6627799 Genetic engineered cells having ability to adjust to environment and have plant disease resistance; hybrids
09/30/2003US6627792 Human T cell-engrafted mouse, method for developing same and use thereof
09/30/2003US6627759 Method of isolating stem cells
09/30/2003US6627747 Essential bacterial genes and their use
09/30/2003US6627741 Isolated antibody or fragment thereof that specifically binds to a protein with a specified amino acid sequence, as well as a hybridoma encoding it
09/30/2003US6627739 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease
09/30/2003US6627731 Thrombin derived polypeptides; compositions and methods for use
09/30/2003US6627623 Induction apoptosis
09/30/2003US6627617 Temperature-sensitive regulation of viral vector production
09/30/2003US6627605 Polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders with
09/30/2003US6627442 Methods for stable transduction of cells with hiv-derived viral vectors
09/30/2003US6627441 Characterized by an increase in the concentration of the growth regulator or the intensity of the water stressing during the course of the growth regulator treatment; for making conifer embryos tolerant of freezer storage
09/30/2003US6627439 Cancer diagnosis, therapy; Dna vaccine
09/30/2003US6627438 Nucleotide sequences for use in the generation of amidated peptides
09/30/2003US6627435 Culturing cells, e.g. mammalian embryos, in wells havng inlets and outlets positioned to form a vortex of fluid flow away without direct flow over the cells; eliminates the flushing of exogenous and growth factor surrounding the cells
09/30/2003US6627426 Decreasing toxic impurities from sample; expose sample to preferential air or gas, recover sample, monitor sample for impurities
09/30/2003US6627422 Non-degradable monofilaments; cylinders; use for implantations and treatment of diabetes, haemophilia, anemia, thalassemia, Parkinson's disease and amyotropic lateral sclerosis
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003US6627414 Genetic engineering; overlapping Dna sequences
09/30/2003US6627405 53BP2 complexes
09/30/2003US6627398 System for reproducing and modulating stability and turnover of RNA molecules
09/30/2003US6627230 Method of preparing a bone product by removing cancellous bone matrix
09/30/2003US6627200 Utilization of CD 137 in order to promote the proliferation of peripheral monocytes
09/30/2003US6627191 Viable for at least 14 days in culture without replication or differentiation
09/30/2003US6627186 Treating neutrophil disorders; granulocyte colony stimulating factor (G-CSF)
09/30/2003CA2262465C Neuritin, a neurogene
09/30/2003CA2133759C Evaluation and treatment of patients with progressive immunosuppression
09/30/2003CA1341440C Cdna coding for carcinoembryonic antigen
09/25/2003WO2003078967A2 Stem cell selection and differentiation
09/25/2003WO2003078638A1 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms
09/25/2003WO2003078637A2 Optimizing glycan processing in plants
09/25/2003WO2003078636A1 Transdifferentiation of cells and tissues
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078630A1 INHIBITION OF THE β3 SUBUNIT OF L-TYPE CA2+ CHANNELS
09/25/2003WO2003078619A1 Hybrid and single chain meganucleases and use thereof
09/25/2003WO2003078615A1 Alcohol dehydrogenases with high solvent and temperature stability
09/25/2003WO2003078614A2 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants
09/25/2003WO2003078613A2 Serine hydroxymethyltransferase as a target for herbicides
09/25/2003WO2003078612A1 Skin ectodermal stem cells
09/25/2003WO2003078611A1 Human embryonic fibroblast feeder cells
09/25/2003WO2003078610A1 A method for generating human nervous system cells, tissues, or neural stem cell progenitors from haematopoietic stem cells
09/25/2003WO2003078609A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003WO2003078608A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003WO2003078607A2 Tissue specific signal-plexes to dedifferentiate and redifferentiate cells
09/25/2003WO2003078606A2 In vitro transfection and long-term cultivation of isolated organs
09/25/2003WO2003078600A2 Human monoclonal antibodies to influenza m2 protein and methods of making and using same
09/25/2003WO2003078599A2 Method for generating primate trophoblasts
09/25/2003WO2003078598A2 Methods for using bag expression as a cell differentiation agent and marker
09/25/2003WO2003078597A2 Tissue engineering
09/25/2003WO2003078596A2 Methods and devices for selective disruption of fatty tissue by controlled cooling
09/25/2003WO2003078589A2 Method of identifying genes controlling diferentiation
09/25/2003WO2003078588A2 Primitive and proximal hepatic stem cells
09/25/2003WO2003078586A2 Vascularized tissue for transplantation
09/25/2003WO2003078585A2 Compositions and methods for primate neural cell production
09/25/2003WO2003078568A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
09/25/2003WO2003078567A2 Methods of inducing differentiation in ex vivo expanded stem cells
09/25/2003WO2003078469A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
09/25/2003WO2003078462A2 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner
09/25/2003WO2003078457A1 MUTEINS OF THE C5a ANAPHYLATOXIN, NUCLEIC ACID MOLECULES ENCODING SUCH MUTEINS, AND PHARMACEUTICAL USES OF MUTEINS OF THE C5a ANAPHYLATOXIN
09/25/2003WO2003078453A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003WO2003077880A1 Method for the production of phytoalexins
09/25/2003WO2003077863A2 Method for overexpression of zwitterionic polysaccharides
09/25/2003WO2003077859A2 Method of inducing an enhanced immune response against hiv
09/25/2003WO2003077852A2 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β
09/25/2003WO2003077836A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/25/2003WO2003077658A1 Re-activated t-cells for adoptive immunotherapy
09/25/2003WO2003052118A3 Bgl4 beta-glucosidase and nucleic acids encoding the same
09/25/2003WO2003042411A3 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
09/25/2003WO2003042245B1 Growth hormone variations in humans and their uses
09/25/2003WO2003040313A3 Il-21 antagonists
09/25/2003WO2003035879A3 Promoters to control cell differentiation
09/25/2003WO2003035682A3 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications
09/25/2003WO2003033519A3 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
09/25/2003WO2003031643A9 Methods for regulating co-stimulatory molecule expression with reactive oxygen
09/25/2003WO2003025160A3 Neuron culture medium and use of cholesterol for cultivating, differentiating or proliferating neurons
09/25/2003WO2003022988A3 Adipose-derived stem cells and lattices
09/25/2003WO2003012078A3 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
09/25/2003WO2003010304A3 Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture
09/25/2003WO2003008454A3 Glycoprotein vi fusion proteins
09/25/2003WO2003004659A3 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms
09/25/2003WO2003004627A3 Novel human hepatoma lines, methods for obtaining same and uses thereof
09/25/2003WO2003000907A3 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation
09/25/2003WO2002100998A3 Method for generating diversity
1 ... 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 ... 1827